Literature DB >> 12393856

Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation.

Augustus O Grant1, Michael P Carboni, Valentina Neplioueva, C Frank Starmer, Mirella Memmi, Carlo Napolitano, Silvia Priori.   

Abstract

The function of the 12 positive charges in the 53-residue III/IV interdomain linker of the cardiac Na(+) channel is unclear. We have identified a four-generation family, including 17 gene carriers with long QT syndrome, Brugada syndrome, and conduction system disease with deletion of lysine 1500 (DeltaK1500) within the linker. Three family members died suddenly. We have examined the functional consequences of this mutation by measuring whole-cell and single-channel currents in 293-EBNA cells expressing the wild-type and DeltaK1500 mutant channel. The mutation shifted V(1/2)h( infinity ) to more negative membrane potentials and increased k(h) consistent with a reduction of inactivation valence of 1. The shift in h( infinity ) was the result of an increase in closed-state inactivation rate (11-fold at -100 mV). V(1/2)m was shifted to more positive potentials, and k(m) was doubled in the DeltaK1500 mutant. To determine whether the positive charge deletion was the basis for the gating changes, we performed the mutations K1500Q and K1500E (change in charge, -1 and -2, respectively). For both mutations, V(1/2)h was shifted back toward control; however, V(1/2)m shifted progressively to more positive potentials. The late component of Na(+) current was increased in the DeltaK1500 mutant channel. These changes can account for the complex phenotype in this kindred and point to an important role of the III/IV linker in channel activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393856      PMCID: PMC150793          DOI: 10.1172/JCI15570

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Contributions of charged residues in a cytoplasmic linking region to Na channel gating.

Authors:  J R Miller; M K Patel; J E John; J P Mounsey; J R Moorman
Journal:  Biochim Biophys Acta       Date:  2000-12-20

2.  Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.

Authors:  D W Wang; N Makita; A Kitabatake; J R Balser; A L George
Journal:  Circ Res       Date:  2000-10-13       Impact factor: 17.367

3.  A single Na(+) channel mutation causing both long-QT and Brugada syndromes.

Authors:  C Bezzina; M W Veldkamp; M P van Den Berg; A V Postma; M B Rook; J W Viersma; I M van Langen; G Tan-Sindhunata; M T Bink-Boelkens; A H van Der Hout; M M Mannens; A A Wilde
Journal:  Circ Res       Date:  1999 Dec 3-17       Impact factor: 17.367

4.  Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes.

Authors:  L Zhang; K W Timothy; G M Vincent; M H Lehmann; J Fox; L C Giuli; J Shen; I Splawski; S G Priori; S J Compton; F Yanowitz; J Benhorin; A J Moss; P J Schwartz; J L Robinson; Q Wang; W Zareba; M T Keating; J A Towbin; C Napolitano; A Medina
Journal:  Circulation       Date:  2000-12-05       Impact factor: 29.690

5.  Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel.

Authors:  M W Veldkamp; P C Viswanathan; C Bezzina; A Baartscheer; A A Wilde; J R Balser
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

6.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.

Authors:  R Dumaine; J A Towbin; P Brugada; M Vatta; D V Nesterenko; V V Nesterenko; J Brugada; R Brugada; C Antzelevitch
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

7.  The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge.

Authors:  S G Priori; C Napolitano; P J Schwartz; R Bloise; L Crotti; E Ronchetti
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

8.  Functional suppression of sodium channels by beta(1)-subunits as a molecular mechanism of idiopathic ventricular fibrillation.

Authors:  X Wan; Q Wang; G E Kirsch
Journal:  J Mol Cell Cardiol       Date:  2000-10       Impact factor: 5.000

9.  Accelerated inactivation in a mutant Na(+) channel associated with idiopathic ventricular fibrillation.

Authors:  X Wan; S Chen; A Sadeghpour; Q Wang; G E Kirsch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-01       Impact factor: 4.733

10.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Authors:  G X Yan; C Antzelevitch
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

View more
  66 in total

Review 1.  Unraveling monogenic channelopathies and their implications for complex polygenic disease.

Authors:  J Jay Gargus
Journal:  Am J Hum Genet       Date:  2003-03-07       Impact factor: 11.025

Review 2.  Defective cardiac ion channels: from mutations to clinical syndromes.

Authors:  Colleen E Clancy; Robert S Kass
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 3.  Inherited disorders of voltage-gated sodium channels.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

4.  New aspects of vulnerability in heterogeneous models of ventricular wall and its modulation by loss of cardiac sodium channel function.

Authors:  A Kapela; N Tsoukias; A Bezerianos
Journal:  Med Biol Eng Comput       Date:  2005-05       Impact factor: 2.602

5.  Diversity in cardiac sodium channel disease phenotype in transgenic mice carrying a single SCN5A mutation.

Authors:  C A Remme; A O Verkerk; A A M Wilde; M W Veldkamp; J M T de Bakker; C R Bezzina
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

Review 6.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

7.  Sirtuin 1 regulates cardiac electrical activity by deacetylating the cardiac sodium channel.

Authors:  Ajit Vikram; Christopher M Lewarchik; Jin-Young Yoon; Asma Naqvi; Santosh Kumar; Gina M Morgan; Julia S Jacobs; Qiuxia Li; Young-Rae Kim; Modar Kassan; Jing Liu; Mohanad Gabani; Ajay Kumar; Haider Mehdi; Xiaodong Zhu; Xiaoqun Guan; William Kutschke; Xiaoming Zhang; Ryan L Boudreau; Shengchuan Dai; Daniel S Matasic; Saet-Byel Jung; Kenneth B Margulies; Vikas Kumar; Markus M Bachschmid; Barry London; Kaikobad Irani
Journal:  Nat Med       Date:  2017-02-13       Impact factor: 53.440

8.  SCN5A (NaV1.5) Variant Functional Perturbation and Clinical Presentation: Variants of a Certain Significance.

Authors:  Brett M Kroncke; Andrew M Glazer; Derek K Smith; Jeffrey D Blume; Dan M Roden
Journal:  Circ Genom Precis Med       Date:  2018-05

9.  Na(+) channel I-II loop mediates parallel genetic and phosphorylation-dependent gating changes.

Authors:  Donald M Bers; Anthony W Herren
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

10.  The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.

Authors:  Naomasa Makita; Elijah Behr; Wataru Shimizu; Minoru Horie; Akihiko Sunami; Lia Crotti; Eric Schulze-Bahr; Shigetomo Fukuhara; Naoki Mochizuki; Takeru Makiyama; Hideki Itoh; Michael Christiansen; Pascal McKeown; Koji Miyamoto; Shiro Kamakura; Hiroyuki Tsutsui; Peter J Schwartz; Alfred L George; Dan M Roden
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.